167 related articles for article (PubMed ID: 16471175)
1. Class of antihypertensive drugs, blood pressure status, and risk of cardiovascular disease in hypertensive patients: a case-control study in Japan.
Kono S; Kushiro T; Hirata Y; Hamada C; Takahashi A; Yoshida Y
Hypertens Res; 2005 Oct; 28(10):811-7. PubMed ID: 16471175
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
4. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
5. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
7. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
8. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
9. [Success of blood pressure reduction in diabetic patients].
Schernthaner G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
[TBL] [Abstract][Full Text] [Related]
10. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
[TBL] [Abstract][Full Text] [Related]
11. Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.
Hartung R; Matzkin H; Alcaraz A; Emberton M; Harving N; van Moorselaar J; Elhilali M; Vallancien G;
J Urol; 2006 Feb; 175(2):624-8; discussion 628. PubMed ID: 16407011
[TBL] [Abstract][Full Text] [Related]
12. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
15. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
Krupicka J; Ceypová K; Kristenová P; Hauser T
Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
[TBL] [Abstract][Full Text] [Related]
16. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
18. Influence of microalbuminuria in achieving blood pressure goals.
Duka I; Bakris G
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
[TBL] [Abstract][Full Text] [Related]
19. New onset diabetes during antihypertensive therapy.
Alderman MH
Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139
[TBL] [Abstract][Full Text] [Related]
20. Treating high blood pressure in diabetes: the evidence.
Adler AI
Semin Vasc Med; 2002 May; 2(2):127-37. PubMed ID: 16222604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
